Novartis AG
NVSNYSEHealthcare● Active
$147.71
$-1.45(-0.97%)
Market Cap$281.8B
P/E Ratio—
52W High$170.46
52W Low$112.34
Novartis AG (NVS) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · NVS · as of 2026-06-08
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $54.81B | $51.72B | $46.66B | $43.46B | $43.97B |
| Cost of Revenue | $13.69B | $12.83B | $12.47B | $11.58B | $11.73B |
| Gross Profit | $41.12B | $38.90B | $34.19B | $31.88B | $32.24B |
| Gross Margin %(computed) | 75.02% | 75.20% | 73.27% | 73.35% | 73.31% |
| Operating Expenses | |||||
| R&D Expenses | $10.74B | $10.02B | $11.37B | $9.17B | $8.64B |
| G&A Expenses | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Total Operating Expenses | $24.05B | $24.35B | $24.42B | $23.93B | $22.18B |
| Operating Income | $17.07B | $14.54B | $9.77B | $7.95B | $10.06B |
| Operating Margin %(computed) | 31.15% | 28.12% | 20.94% | 18.28% | 22.87% |
| Interest Income | $0.37B | $0.57B | $0.63B | $0.38B | $0.07B |
| Interest Expense | $1.19B | $1.04B | $0.88B | $0.83B | $0.91B |
| Income Before Tax | $16.44B | $13.64B | $9.12B | $7.18B | $24.53B |
| Income Tax Expense | $2.40B | $1.70B | $0.55B | $1.13B | $1.63B |
| Net Income | $14.06B | $11.94B | $14.85B | $6.96B | $24.02B |
| Net Margin %(computed) | 25.64% | 23.09% | 31.83% | 16.00% | 54.63% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $7.25 | $5.92 | $7.15 | $3.19 | $10.71 |
| Wtd Avg Shares | 1.94B | 2.02B | 2.08B | 2.18B | 2.24B |
| EBITDA | $22.99B | $20.71B | $18.25B | $14.68B | $30.91B |
| EBITDA Margin %(computed) | 41.94% | 40.05% | 39.12% | 33.78% | 70.30% |
Data source: Financial Modeling Prep · Last updated: 2026-06-08 · USD · B
Explore more Novartis AG data
About Novartis AG (NVS) Income Statement
Novartis AG (NVS) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, NVS reported revenue of $54.81B, gross profit of $41.12B (gross margin 75.02%), and net income of $14.06B — a net profit margin of 25.64%.
Frequently asked questions
NVS · 4 questionsNovartis AG (NVS) reported revenue of $54.81B for 2025, up 6.0% year-over-year.
NVS revenueNVS salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08